Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STRUCTURE-BASED DESIGN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 281 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barry, C; Cole, S; Fourie, B; Geiter, L; Gosey, L; Grosset, J; Kanyok, T; Laughon, B; Mitchison, D; Nunn, P; O'Brien, R; Robinson, T; Annick-Mouries, M; Cynamon, M; Duncan, K; Goldberger, M; Gutteridege, W; Kioy, D; Pablos-Mendez, A; Orme, I; Rieder, H; Roscigno, G; Vernon, A
      Scientific blueprint for tuberculosis drug development - Global alliance for TB drug development

      TUBERCULOSIS
    2. Springer, DM
      An update on inhibitors of human 14 kDa Type II s-PLA(2) in development

      CURRENT PHARMACEUTICAL DESIGN
    3. Rodriguez, JB
      Specific molecular targets to control tropical diseases

      CURRENT PHARMACEUTICAL DESIGN
    4. Cazzulo, JJ; Stoka, V; Turk, V
      The major cysteine proteinase of Trypanosoma cruzi: A valid target for chemotherapy of Chagas disease

      CURRENT PHARMACEUTICAL DESIGN
    5. Shakespeare, WC
      SH2 domain inhibition: a problem solved?

      CURRENT OPINION IN CHEMICAL BIOLOGY
    6. Tranter, D
      Phosphinate isosteres of phosphotyrosine for incorporation in Crb2-SH2 inhibitors

      DRUG DISCOVERY TODAY
    7. Sawyer, T; Boyce, B; Dalgarno, D; Iuliucci, J
      Src inhibitors: genomics to therapeutics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    8. Neamati, N
      Structure-based HIV-1 integrase inhibitor design: a future perspective

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Dragovich, PS
      Recent advances in the development of human rhinovirus 3C protease inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    10. Brailsford, T; Burt, C; Calder, J; Davies, M; Edge, C; Murray-Rust, P; Overington, J; Richardson, CM
      Virtual education for medicinal chemistry: Early experiences in industrial-academic partnership for continuous learning.

      INTERNET JOURNAL OF CHEMISTRY
    11. De Jong, RL; Davidson, JG; Dozeman, GJ; Fiore, PJ; Giri, P; Kelly, ME; Puls, TP; Seamans, RE
      The chemical development of CI-972 and CI-1000: A continuous nitration, a MgCl2/Et3N-mediated C-alkylation of a chloronitropyrimidine, a catalytic protodediazotization of a diazonium salt, and an air oxidation of an amine

      ORGANIC PROCESS RESEARCH & DEVELOPMENT
    12. Tondi, D; Powers, RA; Caselli, E; Negri, MC; Blazquez, J; Costi, MP; Shoichet, BK
      Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase

      CHEMISTRY & BIOLOGY
    13. Anderson, AC; O'Neil, RH; Surti, TS; Stroud, RM
      Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking

      CHEMISTRY & BIOLOGY
    14. Fritz, TA; Tondi, D; Finer-Moore, JS; Costi, MP; Stroud, RM
      Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase

      CHEMISTRY & BIOLOGY
    15. Caselli, E; Powers, RA; Blasczcak, LC; Wu, CYE; Prati, F; Shoichet, BK
      Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases

      CHEMISTRY & BIOLOGY
    16. Wang, BS; Grant, RA; Pabo, CO
      Selected peptide extension contacts hydrophobic patch on neighboring zinc finger and mediates dimerization on DNA

      NATURE STRUCTURAL BIOLOGY
    17. Vidal, M; Gigoux, V; Garbay, C
      SH2 and SH3 domains as targets for anti-proliferative agents

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    18. Ferguson, AD; Kodding, J; Walker, G; Bos, C; Coulton, JW; Diederichs, K; Braun, V; Welte, W
      Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA

      STRUCTURE
    19. Liao, DI; Wawrzak, Z; Calabrese, JC; Viitanen, PV; Jordan, DB
      Crystal structure of riboflavin synthase

      STRUCTURE
    20. Lee, JE; Cornell, KA; Riscoe, MK; Howell, PL
      Structure of E-coli 5 '-methylthioadenosine/S-adenosylhomocysteine nucleosidase reveals similarity to the purine nucleoside phosphorylases

      STRUCTURE
    21. Burke, TR; Yao, ZJ; Gao, Y; Wu, JX; Zhu, XF; Luo, JH; Guo, RB; Yang, DJ
      N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding

      BIOORGANIC & MEDICINAL CHEMISTRY
    22. Maguire, AR; Plunkett, SJ; Papot, S; Clynes, M; O'Connor, R; Touhey, S
      Synthesis of indomethacin analogues for evaluation as modulators of MRP activity

      BIOORGANIC & MEDICINAL CHEMISTRY
    23. Qiu, XY; Janson, CA; Smith, WW; Green, SM; McDevitt, P; Johanson, K; Carter, P; Hibbs, M; Lewis, C; Chalker, A; Fosberry, A; Lalonde, J; Berge, J; Brown, P; Houge-Frydrych, CSV; Jarvest, RL
      Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors

      PROTEIN SCIENCE
    24. Schoepfer, J; Gay, B; End, N; Muller, E; Scheffel, G; Caravatti, G; Furet, P
      Convergent synthesis of potent peptide inhibitors of the Grb2-SH2 domain by palladium catalyzed coupling of a terminal alkyne

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    25. Venkatachalam, TK; Sudbeck, EA; Mao, C; Uckun, FM
      Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    26. Fray, MJ; Burslem, MF; Dickinson, RP
      Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on p3 ' group chirality

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    27. Gohda, K; Ohta, D; Kozaki, A; Fujimori, K; Mori, I; Kikuchi, T
      Identification of novel potent inhibitors for ATP-phosphoribosyl transferase using three-dimensional structural database search technique

      QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS
    28. De Clercq, E
      New developments in anti-HIV chemotherapy

      CURRENT MEDICINAL CHEMISTRY
    29. Garcia-Echeverria, C
      Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70

      CURRENT MEDICINAL CHEMISTRY
    30. So, SS; Karplus, M
      Evaluation of designed ligands by a multiple screening method: Applicationto glycogen phosphorylase inhibitors constructed with a variety of approaches

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    31. Sippl, W; Contreras, JM; Parrot, I; Rival, YM; Wermuth, CG
      Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    32. Zhu, J; Yu, HB; Fan, H; Liu, HY; Shi, YY
      Design of new selective inhibitors of cyclooxygenase-2 by dynamic assemblyof molecular building blocks

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    33. Furet, P; Meyer, T; Mittl, P; Fretz, H
      Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searching

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    34. Luic, M; Koellner, G; Shugar, D; Saenger, W; Bzowska, A
      Calf spleen purine nucleoside phosphorylase: structure of its ternary complex with an N(7)-acycloguanosine inhibitor and a phosphate anion

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    35. Verkhivker, GM; Bouzida, D; Gehlhaar, DK; Rejto, PA; Schaffer, L; Arthurs, S; Colson, AB; Freer, ST; Larson, V; Luty, BA; Marrone, T; Rose, PW
      Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: Structural analysis of the peptide complexes with SH2 domains

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    36. Lee, JY; Kim, SN; Lee, CK; Park, H; Lee, YS
      Two sulfonamides-containing dihydropyrone derivatives as HIV protease inhibitors

      ARCHIV DER PHARMAZIE
    37. Muller, G
      Peptidomimetic SH2 domain antagonists for targeting signal transduction

      BIOORGANIC CHEMISTRY OF BIOLOGICAL SIGNAL TRANSDUCTION
    38. Montclare, JK; Sloan, LS; Schepartz, A
      Electrostatic control of half-site spacing preferences by the cyclic AMP response element-binding protein CREB

      NUCLEIC ACIDS RESEARCH
    39. Kumar, CC; Diao, R; Yin, ZZ; Liu, YH; Samatar, AA; Madison, V; Xiao, L
      Expression, purification, characterization and homology modeling of activeAkt/PKB, a key enzyme involved in cell survival signaling

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    40. English, AC; Groom, CR; Hubbard, RE
      Experimental and computational mapping of the binding surface of a crystalline protein

      PROTEIN ENGINEERING
    41. Budin, N; Majeux, N; Tenette-Souaille, C; Caflisch, A
      Structure-based ligand design by a build-up approach and genetic algorithmsearch in conformational space

      JOURNAL OF COMPUTATIONAL CHEMISTRY
    42. Stoychev, G; Kierdaszuk, B; Shugar, D
      Interaction of Escherichia coli purine nucleoside phosphorylase (PNP) withthe cationic and zwitterionic forms of the fluorescent substrate N(7)-methylguanosine

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    43. Zhang, KYE; Hee, B; Lee, CA; Liang, BH; Potts, BCM
      Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease

      DRUG METABOLISM AND DISPOSITION
    44. Aronov, AM; Munagala, NR; Kuntz, ID; Wang, CC
      Virtual screening of combinatorial libraries across a gene family: in search of inhibitors of Giardia lamblia guanine phosphoribosyltransferase

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    45. Nelson, RG; Rosowsky, A
      Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: Structure-activity and structure-selectivity correlations

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    46. Huff, JR; Kahn, J
      Discovery and clinical development of HIV-1 protease inhibitors

      ADVANCES IN PROTEIN CHEMISTRY, VOL 56
    47. Vieira, PC; Mafezoli, J; Pupo, MT; Fernandex, JB; da Silva, MFDF; de Albuquerque, S; Oliva, G; Pavao, F
      Strategies for the isolation and identification of trypanocidal compounds from the Rutales

      PURE AND APPLIED CHEMISTRY
    48. De Clercq, E
      New developments in anti-HIV chemotherapy

      PURE AND APPLIED CHEMISTRY
    49. Poole, K
      Overcoming antimicrobial resistance by targeting resistance mechanisms

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    50. Claussen, H; Buning, C; Rarey, M; Lengauer, T
      FlexE: Efficient molecular docking considering protein structure variations

      JOURNAL OF MOLECULAR BIOLOGY
    51. Katz, BA; Elrod, K; Luong, C; Rice, MJ; Mackman, RL; Sprengeler, PA; Spencer, J; Hataye, J; Janc, J; Link, J; Litvak, J; Rai, R; Rice, K; Sideris, S; Verner, E; Young, W
      A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site

      JOURNAL OF MOLECULAR BIOLOGY
    52. Soper, DL; Milbank, JBJ; Mieling, GE; Dirr, MJ; Kende, AS; Cooper, R; Jee, WSS; Yao, W; Chen, JL; Bodman, M; Lundy, MW; De, B; Stella, ME; Ebetino, FH; Wang, YL; deLong, MA; Wos, JA
      Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis

      JOURNAL OF MEDICINAL CHEMISTRY
    53. Proudfoot, JR; Betageri, R; Cardozo, M; Gilmore, TA; Glynn, S; Hickey, ER; Jakes, S; Kabcenell, A; Kirrane, TM; Tibolla, AK; Lukas, S; Patel, UR; Sharma, R; Yazdanian, M; Moss, N; Beaulieu, PL; Cameron, DR; Ferland, JM; Gauthier, J; Gillard, J; Gorys, V; Poirier, M; Rancourt, J; Wernic, D; Llinas-Brunet, M
      Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain

      JOURNAL OF MEDICINAL CHEMISTRY
    54. Charitos, C; Kokotos, G; Tzougraki, C
      Bifunctional coumarin derivatives in solution and solid phase synthesis offluorogenic enzyme substrates

      JOURNAL OF HETEROCYCLIC CHEMISTRY
    55. Opperdoes, FR; Michels, PAM
      Enzymes of carbohydrate metabolism as potential drug targets

      INTERNATIONAL JOURNAL FOR PARASITOLOGY
    56. Pang, YP; Xu, K; Kollmeyer, TM; Perola, E; McGrath, WJ; Green, DT; Mangel, WF
      Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases

      FEBS LETTERS
    57. Bridges, AJ
      Chemical inhibitors of protein kinases

      CHEMICAL REVIEWS
    58. Reddy, MR; Erion, MD
      Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    59. Terstappen, GC; Reggiani, A
      In silico research in drug discovery

      TRENDS IN PHARMACOLOGICAL SCIENCES
    60. Clare, BW; Scozzafava, A; Briganti, F; Iorga, B; Supuran, CT
      Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: Synthesis and structure-activity correlations

      JOURNAL OF ENZYME INHIBITION
    61. Wang, RX; Gao, Y; Lai, LH
      LigBuilder: A multi-purpose program for structure-based drug design

      JOURNAL OF MOLECULAR MODELING
    62. Morris, PE; Elliott, AJ; Walton, SP; Williams, CH; Montgomery, JA
      Synthesis and biological activity of a novel class of purine nucleoside phosphorylase inhibitors

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    63. Cockerill, GS; Easterfield, HJ; Percy, JM; Pintat, S
      Facile syntheses of building blocks for the construction of phosphotyrosine mimetics

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    64. Rewcastle, GW; Denny, WA; Showalter, HDH
      Synthesis of 4-(phenylamino)pyrimidine derivatives as ATP-competitive protein kinase inhibitors with potential for cancer chemotherapy

      CURRENT ORGANIC CHEMISTRY
    65. Morris, PE; Omura, GA
      Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis

      CURRENT PHARMACEUTICAL DESIGN
    66. Cody, WL; Lin, ZW; Panek, RL; Rose, DW; Rubin, JR
      Progress in the development of inhibitors of SH2 domains

      CURRENT PHARMACEUTICAL DESIGN
    67. Page, MGF
      beta-lactamase inhibitors

      DRUG RESISTANCE UPDATES
    68. Pathak, VP
      Selective formation of pyrrola[3,2-d]pyrimidines from methyl[(N-benzoyl-S-methylisoihiocarbamoyl)amino]-1H-pyrrole-2-carboxylate

      ORGANIC PROCESS RESEARCH & DEVELOPMENT
    69. Du, XH; Hansell, E; Engel, JC; Caffrey, CR; Cohen, FE; McKerrow, JH
      Aryl ureas represent a new class of anti-trypanosomal agents

      CHEMISTRY & BIOLOGY
    70. Freymann, DM; Wenck, MA; Engel, JC; Feng, J; Focia, PJ; Eakin, AE; Craig, SP
      Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi

      CHEMISTRY & BIOLOGY
    71. Wolfe, SA; Nekludova, L; Pabo, CO
      DNA recognition by Cys(2)His(2) zinc finger proteins

      ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE
    72. De Clercq, E
      Novel compounds in preclinical/early clinical development for the treatment of HIV infections

      REVIEWS IN MEDICAL VIROLOGY
    73. Wolfe, SA; Ramm, EI; Pabo, CO
      Combining structure-based design with phage display to create new Cys(2)His(2) zinc finger dimers

      STRUCTURE WITH FOLDING & DESIGN
    74. von Matt, A; Ehrhardt, C; Burkhard, P; Metternich, R; Walkinshaw, M; Tapparelli, C
      Selective boron-containing thrombin inhibitors - X-ray analysis reveals surprising binding mode

      BIOORGANIC & MEDICINAL CHEMISTRY
    75. Henriques, DA; Ladbury, JE; Jackson, RM
      Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization

      PROTEIN SCIENCE
    76. Chirgadze, NY; Sall, DJ; Briggs, SL; Clawson, DK; Zhang, M; Smith, GF; Schevitz, RW
      The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: A binding mode for a structurally novel class of inhibitors

      PROTEIN SCIENCE
    77. Gao, Y; Wu, L; Luo, JH; Guo, R; Yang, D; Zhang, ZY; Burke, TR
      Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    78. Venkatachalam, TK; Sudbeck, EA; Mao, C; Uckun, FM
      Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a majordeterminant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    79. Choo, Y; Isalan, M
      Advances in zinc finger engineering

      CURRENT OPINION IN STRUCTURAL BIOLOGY
    80. Venkatachalam, TK; Sudbeck, EA; Mao, C; Uckun, FM
      Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    81. Al-Obeidi, FA; Lam, KS
      Development of inhibitors for protein tyrosine kinases

      ONCOGENE
    82. Masjost, B; Ballmer, P; Borroni, E; Zurcher, G; Winkler, FK; Jakob-Roetne, R; Diederich, F
      Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT)

      CHEMISTRY-A EUROPEAN JOURNAL
    83. Werbovetz, KA
      Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis

      CURRENT MEDICINAL CHEMISTRY
    84. Huang, LM
      Recent advances in the study, prevention, and treatment of infectious diseases

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    85. Elkin, CD; Zuccola, HJ; Hogle, JM; Joseph-McCarthy, D
      Computational design of D-peptide inhibitors of hepatitis delta antigen dimerization

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    86. Filikov, AV; Mohan, V; Vickers, TA; Griffey, RH; Cook, PD; Abagyan, RA; James, TL
      Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    87. Furet, P; Zimmermann, J; Capraro, HG; Meyer, T; Imbach, P
      Structure-based design of potent CDK1 inhibitors derived from olomoucine

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    88. Caflisch, A; Schramm, HJ; Karplus, M
      Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    89. Jalaie, M; Erickson, JA
      Homology model directed alignment selection for comparative molecular field analysis: Application to photosystem II inhibitors

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    90. Lightstone, FC; Prieto, MC; Singh, AK; Piqueras, MC; Whittal, RM; Knapp, MS; Balhorn, R; Roe, DC
      Identification of novel small molecule ligands that bind to tetanus toxin

      CHEMICAL RESEARCH IN TOXICOLOGY
    91. Boschelli, DH; Boschelli, F
      Small molecule inhibitors of Src family kinases

      DRUGS OF THE FUTURE
    92. Lee, YS; Kim, SN; Lee, YS; Lee, JY; Lee, CK; Kim, HS; Park, H
      Synthesis and HIV protease inhibitory activity of new 4-hydroxy-2-pyrone derivatives

      ARCHIV DER PHARMAZIE
    93. Oakley, AJ; Wilce, MCJ
      Macromolecular crystallography as a tool for investigating drug, enzyme and receptor interactions

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    94. Larder, BA; Hertogs, K; Bloor, S; van den Eynde, C; DeCian, W; Wang, YY; Freimuth, WW; Tarpley, G
      Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

      AIDS
    95. Fry, DW
      Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer

      ANTI-CANCER DRUG DESIGN
    96. Gussio, R; Zaharevitz, DW; McGrath, CF; Pattabiraman, N; Kellogg, GE; Schultz, C; Link, A; Kunick, C; Leost, M; Meijer, L; Sausville, EA
      Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition

      ANTI-CANCER DRUG DESIGN
    97. Chirgadze, NY; Briggs, SL; McAllister, KA; Fischl, AS; Zhao, GS
      Crystal structure of Streptococcus pneumoniae acyl carrier protein synthase: an essential enzyme in bacterial fatty acid biosynthesis

      EMBO JOURNAL
    98. Kellogg, GE; Abraham, DJ
      Hydrophobicity: is LogP(o/w) more than the sum of its parts?

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    99. Garcia-Echeverria, C; Traxler, P; Evans, DB
      ATP site-directed competitive and irreversible inhibitors of protein kinases

      MEDICINAL RESEARCH REVIEWS
    100. Kierdaszuk, B; Modrak-Wojcik, A; Wierzchowski, J; Shugar, D
      Formycin A and its N-methyl analogues, specific inhibitors of E-coli purine nucleoside phosphorylase (PNP): induced tautomeric shifts on binding to enzyme, and enzyme -> ligand fluorescence resonance energy transfer

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 08:33:28